Herb Cross - Jun 13, 2022 Form 4 Insider Report for Atreca, Inc. (BCEL)

Role: Chief Financial Officer
Signature: /s/ Herbert Cross
Stock symbol: BCEL
Transactions as of: Jun 13, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/15/2022, 07:14 PM
Previous filing: Dec 28, 2021
Next filing: Aug 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCEL	Employee stock option (right to buy)	Award		+95K			95K	Jun 13, 2022	Class A Common Stock	95K	$1.85	Direct	F1, F2
transaction	BCEL	Employee stock option (right to buy)	Disposed to Issuer	$0	-95K	-100%	$0.00^*	0	Jun 13, 2022	Class A Common Stock	95K	$13.97	Direct	F1
transaction	BCEL	Employee stock option (right to buy)	Award		+225K			225K	Jun 13, 2022	Class A Common Stock	225K	$1.85	Direct	F2, F3
transaction	BCEL	Employee stock o16.74ption (right to buy)	Disposed to Issuer	$0	-225K	-100%	$0.00^*	0	Jun 13, 2022	Class A Common Stock	225K	$12.06	Direct	F3
transaction	BCEL	Employee stock option (right to buy)	Award		+97K			97K	Jun 13, 2022	Class A Common Stock	97K	$1.85	Direct	F2, F4
transaction	BCEL	Employee stock option (right to buy)	Disposed to Issuer	$0	-97K	-100%	$0.00^*	0	Jun 13, 2022	Class A Common Stock	97K	$22.07	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/48 of the Option vests in equal monthly installments as measured from 1/1/2021. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
F2	The transactions reported herein reflect a one-time stock option repricing effective on June 13, 2022 (the "Option Repricing"). The Option Repricing applies to options with exercise prices greater than or equal to $9.00 per share held by all employees of the Issuer as of June 13, 2022. Pursuant to the Option Repricing, the exercise price of the repriced options, including the Option, has been amended to reduce the exercise price to $1.845 per share, the closing price of the Issuer's Class A common stock on the Nasdaq Global Select Market as of the date of the Option Repricing. There have been no other changes to the terms of the repriced options, including the Option. The Option Repricing does not apply to options held by non-employee directors of the Issuer.
F3	1/4 of the Option vests on 2/25/2020 and 1/48 of the Option vests in equal monthly installments as measured from 2/25/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
F4	2/48 of the Option vests on 3/1/2020 and 1/48 of the Option vests in equal monthly installments as measured from 3/1/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.